Christian Bastard

Title: Christian Bastard: Innovator in Hematopoietic Neoplasms

Introduction

Christian Bastard is a notable inventor based in Ardouval, France. He has made significant contributions to the field of medical diagnostics, particularly in the area of hematopoietic neoplasms. With a total of six patents to his name, his work has the potential to impact the diagnosis and treatment of various blood-related cancers.

Latest Patents

One of Christian Bastard's latest patents focuses on the use of TET2 as a diagnostic and prognostic marker in hematopoietic neoplasms. This invention describes an in vitro method for diagnosing myeloid or lymphoid tumors in a subject. The method involves analyzing a biological sample to detect mutations in the Ten Eleven Translocation protein family member 2 gene (TET2) or assessing the expression of the TET2 gene. The presence of a TET2 mutation or the absence of TET2 expression can indicate a subject's predisposition to develop these types of tumors.

Career Highlights

Throughout his career, Christian Bastard has worked with prestigious institutions such as the National Institute of Health and Medical Research and Gustave Roussy Institute. His work in these organizations has allowed him to advance his research and contribute to the medical community.

Collaborations

Christian has collaborated with notable colleagues, including Franck Viguie and Olivier Bernard. These partnerships have further enriched his research and innovation efforts.

Conclusion

Christian Bastard is a prominent figure in the field of medical diagnostics, particularly in relation to hematopoietic neoplasms. His innovative patents and collaborations highlight his commitment to advancing healthcare through scientific research.